ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancersNa Jing, Helen He Zhu, Xinyu Chen et al.|Journal of Clinical Investigation|2023Cited by 29
The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancerYiyi Ji, Wei Xue|Nature Communications|2023Cited by 16
Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathwayYiyi Ji, Wei Xue|Cellular Oncology|2023Cited by 11